Cancer Journal (United States)
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 29.4% | 0.869 | Q2 | 79.9% |
| 2024 | 2.2 | Q3 | 34.0% | 0.956 | Q2 | 83.0% |
| 2023 | 2.6 | Q3 | 42.9% | 0.933 | Q2 | 83.8% |
| 2022 | 2.2 | Q4 | 28.3% | 0.880 | Q2 | 83.2% |
| 2021 | 2.1 | Q4 | 31.5% | 1.027 | Q2 | 87.1% |
| 2020 | — | — | 1.825 | Q1 | 94.7% | |
| 2019 | — | — | 1.491 | Q1 | 92.6% | |
| 2018 | — | — | 1.499 | Q1 | 91.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1540-336X
ISSN
1528-9117
country
UScoverage
1996, 1998, 2000-2026